Cargando…
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
Although the ever-increasing number of cancer patients pose substantial challenges worldwide, finding a treatment with the highest response rate and the lowest number of side effects is still undergoing research. Compared to chemotherapy, the relatively low side effects of cancer immunotherapy have...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663909/ https://www.ncbi.nlm.nih.gov/pubmed/33167514 http://dx.doi.org/10.3390/ijms21218305 |